United States
# |
Name |
Revenue Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 68,343.25
|
Sept. 30, 2023 | USD 4.62 | -0.22% |
|
United States |
|
2 |
USD 2,531.62
|
Sept. 30, 2024 | USD 593.73 | 1.48% |
|
United States |
|
3 |
USD 1,476.72
|
Sept. 30, 2024 | USD 240.05 | 1.68% |
|
United States |
|
4 |
USD 949.93
|
Sept. 30, 2024 | USD 282.63 | -1.65% |
|
United States |
|
5 |
USD 921.03
|
Sept. 30, 2024 | USD 124.03 | 2.62% |
|
United States |
|
6 |
USD 810.39
|
Sept. 30, 2024 | USD 285.03 | 0.91% |
|
United States |
|
7 |
USD 747.65
|
Sept. 30, 2024 | USD 393.16 | -0.84% |
|
United States |
|
8 |
USD 677.23
|
Sept. 30, 2024 | USD 294.03 | -0.14% |
|
United States |
|
9 |
USD 423.76
|
Sept. 30, 2024 | USD 543.74 | 0.48% |
|
United States |
|
10 |
USD 305.01
|
Sept. 30, 2024 | USD 63.40 | -0.47% |
|
United States |
|
11 |
USD 291.46
|
Sept. 30, 2024 | USD 51.57 | 0.10% |
|
United States |
|
12 |
USD 265.54
|
Sept. 30, 2024 | USD 305.79 | -0.78% |
|
United States |
|
13 |
USD 229.75
|
Sept. 30, 2024 | USD 184.16 | -0.85% |
|
United States |
|
14 |
USD 213.20
|
Sept. 30, 2024 | USD 127.63 | -1.27% |
|
United States |
|
15 |
USD 196.11
|
Sept. 30, 2024 | USD 5.93 | -10.83% |
|
United States |
|
16 |
USD 175.81
|
Sept. 30, 2024 | USD 1.27 K | 0.33% |
|
United States |
|
17 |
USD 174.23
|
Nov. 30, 2024 | USD 12.24 | 2.86% |
|
United States |
|
18 |
USD 157.58
|
Sept. 30, 2024 | USD 534.10 | 0.75% |
|
United States |
|
19 |
USD 150.85
|
Sept. 30, 2024 | USD 234.50 | 0.17% |
|
United States |
|
20 |
USD 145.28
|
Sept. 30, 2024 | USD 162.00 | 3.15% |
|
United States |
|
21 |
USD 139.17
|
Sept. 30, 2024 | USD 14.74 | 1.17% |
|
United States |
|
22 |
USD 138.28
|
Nov. 30, 2024 | USD 20.73 | 0.34% |
|
United States |
|
23 |
USD 128.63
|
Sept. 30, 2024 | USD 690.87 | -3.63% |
|
United States |
|
24 |
USD 122.44
|
Sept. 30, 2024 | USD 7.37 | 0.96% |
|
United States |
|
25 |
USD 110.55
|
Sept. 28, 2024 | USD 556.99 | 0.27% |
|
United States |
|
26 |
USD 105.10
|
Nov. 30, 2023 | USD 11.35 | -0.53% |
|
United States |
|
27 |
USD 97.56
|
Sept. 28, 2024 | USD 71.27 | 0.81% |
|
United States |
|
28 |
USD 96.28
|
Sept. 30, 2024 | USD 161.08 | 1.85% |
|
United States |
|
29 |
USD 95.27
|
Sept. 30, 2024 | USD 2.91 | -3.32% |
|
United States |
|
30 |
USD 93.00
|
Sept. 30, 2024 | USD 23.67 | -0.80% |
|
United States |
|
31 |
USD 90.81
|
Sept. 30, 2024 | USD 342.23 | -2.69% |
|
United States |
|
32 |
USD 84.38
|
Sept. 30, 2024 | USD 197.96 | -3.26% |
|
United States |
|
33 |
USD 80.43
|
Sept. 30, 2024 | USD 26.12 | -5.40% |
|
United States |
|
34 |
USD 80.02
|
Sept. 30, 2024 | USD 97.73 | 0.74% |
|
United States |
|
35 |
USD 78.97
|
Sept. 28, 2024 | USD 178.08 | -6.34% |
|
United States |
|
36 |
USD 75.47
|
Sept. 30, 2024 | USD 31.49 | 2.37% |
|
United States |
|
37 |
USD 73.26
|
Oct. 26, 2024 | USD 30.89 | 0.16% |
|
United States |
|
38 |
USD 72.32
|
Sept. 30, 2024 | USD 133.50 | 0.88% |
|
United States |
|
39 |
USD 71.00
|
Sept. 30, 2024 | USD 91.98 | 0.01% |
|
United States |
|
40 |
USD 69.79
|
Sept. 30, 2024 | USD 14.37 | 0.77% |
|
United States |
|
41 |
USD 69.65
|
Sept. 30, 2024 | USD 235.80 | -0.17% |
|
United States |
|
42 |
USD 67.02
|
Sept. 30, 2024 | USD 330.91 | -5.99% |
|
United States |
|
43 |
USD 64.71
|
Sept. 30, 2024 | USD 143.06 | -4.74% |
|
United States |
|
44 |
USD 64.71
|
Sept. 30, 2024 | USD 12.65 | -16.61% |
|
United States |
|
45 |
USD 64.40
|
Sept. 29, 2024 | USD 179.17 | 0.35% |
|
United States |
|
46 |
USD 60.47
|
Sept. 30, 2024 | USD 267.10 | -1.14% |
|
United States |
|
47 |
USD 60.24
|
Sept. 30, 2024 | USD 364.70 | 0.50% |
|
United States |
|
48 |
USD 59.46
|
Sept. 30, 2024 | USD 17.80 | 3.01% |
|
United States |
|
49 |
USD 57.73
|
Sept. 30, 2024 | USD 362.80 | 0.50% |
|
United States |
|
50 |
USD 56.16
|
Sept. 30, 2024 | USD 18.92 | 0.64% |
|
United States |
The Health Care company in United States with the highest Revenue Per Share is Cingulate Inc. (NasdaqCM: CING) at USD 68,343.25.
The Health Care company in United States with the lowest Revenue Per Share is Larimar Therapeutics, Inc. (NasdaqGM: LRMR) at USD 0.00.
The top 10 Health Care companies in United States by Revenue Per Share are Cingulate Inc., McKesson Corporation, Cencora, Humana Inc., Cardinal Health, Inc., Cigna Corporation, Elevance Health Inc., Molina Healthcare, Inc., UnitedHealth Group Incorporated and Centene Corporation.
The bottom 10 Health Care companies in United States by Revenue Per Share are Larimar Therapeutics, Inc., Lisata Therapeutics, Inc., MEI Pharma, Inc., Apogee Therapeutics, Inc., Annovis Bio, Inc., Vera Therapeutics, Inc., Lexeo Therapeutics, Inc. Common Stock, MAIA Biotechnology, Inc., Anebulo Pharmaceuticals, Inc. and PharmaCyte Biotech, Inc..